MCQ Flashcards
7 cards from real ISMP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 MCQ flashcards as text
According to ISMP, a learning culture is likely the easiest to implement but the most difficult to sustain in the healthcare industry.
Answer: True
A learning culture, while easy to initiate with new policies, requires continuous effort, adaptation, and a shift in mindset to truly embed within an organization. Sustaining this culture in the complex and often high-pressure healthcare environment is challenging due to factors like resistance to change, resource limitations, and the need for ongoing education and reinforcement. Therefore, maintaining it long-term proves more difficult than its initial implementation.
A 2014 ISMP survey on drug dilution procedures revealed.
Answer: None of the above
The question refers to specific findings from a 2014 ISMP survey on drug dilution procedures. Without the exact details of the survey's conclusions, the provided options A, B, and C may not accurately represent the survey's findings or might be incomplete. Therefore, 'None of the above' is the correct choice, indicating that the given statements do not precisely reflect the survey's reported outcomes.
Serious negative incident Reporting of unanticipated and unidentified events could result in:
Answer: All of the above
Reporting serious negative incidents, especially unanticipated or unidentified events, is critical for patient safety. Such reports can trigger a formal risk management plan to investigate root causes and prevent recurrence. They can also lead to a boxed warning on a drug's label to highlight severe risks or necessitate a medication guide to inform patients about safe use and potential side effects. All these actions are crucial responses to mitigate future harm.
Where should healthcare professionals report pharmaceutical errors?
Answer: ISMP, because FDA reports may not collect contact information for follow up and other pertinent information needed for evaluation
Healthcare professionals are encouraged to report medication errors to ISMP because it specializes in medication safety and actively seeks detailed information, including contact details, for follow-up and in-depth analysis. While the FDA also collects reports via MedWatch, ISMP's dedicated focus often allows for a more comprehensive investigation into the root causes of errors and the development of targeted prevention strategies, which frequently requires direct communication with the reporter.
Launched in 2014, the Medication Safety Best Practices for Hospitals include:
Answer: All of the above
The Medication Safety Best Practices for Hospitals, launched by ISMP in 2014, were indeed created to encourage and achieve broad national acceptance, which is occurring nationwide. These practices comprised six carefully chosen, consensus-based interventions. Their primary aim was to address persistent medication safety problems that continued to harm patients despite repeated warnings, providing actionable solutions to common, high-risk issues.
Submitting a MedWatch report may be done by all of the following EXCEPT:
Answer: In person
The FDA's MedWatch program provides several convenient methods for reporting adverse events, product quality problems, and medication errors. These standard methods include online submission, fax, phone, and mail. Reporting 'in person' is not a listed or standard option for submitting a MedWatch report.
Drug makers are required by the Federal Food, Drug, and Cosmetic Act to establish the safety of new medications before they are marketed.
Answer: True
The Federal Food, Drug, and Cosmetic Act (FD&C Act) is a cornerstone of drug regulation in the United States. A fundamental requirement of this act is that drug manufacturers must demonstrate the safety and efficacy of any new medication through rigorous testing and clinical trials before it can be legally marketed and sold to the public. This ensures that drugs meet specific safety standards before patient use.